Labcorp EVP Kirchgraber resigns, receives $2.75M severance and equity acceleration

LABCORP HOLDINGS INC.

Paul Kirchgraber, Sr. Advisor to CEO and former head of Drug Development, resigned effective Sept 1, 2023.
Severance payment of $2,748,997 (2x salary plus average bonus) plus $20,600 medical stipend, $3,000 outplacement.
Equity: RSUs/options vesting within 12 months vest on separation; performance awards continue prorated.
Departure treated as 'good reason' under Labcorp's Severance Plan; includes non-compete/non-solicit.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Paul Kirchgraber

Senior Advisor to the CEO

LH · LABCORP HOLDINGS INC.

Effective: 2023-09-01
Filed: September 11, 2023, 7:59 PM ET

As previously disclosed, on January 4, 2023, Paul Kirchgraber, Senior Advisor to the CEO, and former EVP and CEO of Labcorp’s Drug Development business segment, informed Laboratory Corporation of America Holdings (“Labcorp”) that he intended to depart Labcorp upon the completion of the spin-off of Fortrea Holdings Inc. in order to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Kirchgraber resigned as Senior Advisor to the CEO at LABCORP HOLDINGS INC..

Action: resigned
Role: Senior Advisor to the CEO

Exact text from the filing

As previously disclosed, on January 4, 2023, Paul Kirchgraber, Senior Advisor to the CEO, and former EVP and CEO of Labcorp’s Drug Development business segment, informed Laboratory Corporation of America Holdings (“Labcorp”) that he intended to depart Labcorp upon the completion of the spin-off of Fortrea Holdings Inc. in order to pursue other opportunities.

View on SEC.gov

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0000920148-23-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.